346 related articles for article (PubMed ID: 35321555)
21. High Burden of COVID-19-Associated Pulmonary Aspergillosis in Severely Immunocompromised Patients Requiring Mechanical Ventilation.
Feys S; Lagrou K; Lauwers HM; Haenen K; Jacobs C; Brusselmans M; Debaveye Y; Hermans G; Hoenigl M; Maertens J; Meersseman P; Peetermans M; Spriet I; Vandenbriele C; Vanderbeke L; Vos R; Van Wijngaerden E; Wilmer A; Wauters J
Clin Infect Dis; 2024 Feb; 78(2):361-370. PubMed ID: 37691392
[TBL] [Abstract][Full Text] [Related]
22. Bronchoalveolar lavage fluid galactomannan detection for diagnosis of invasive pulmonary aspergillosis in chronic obstructive pulmonary disease.
Zhang XB; Chen GP; Lin QC; Lin X; Zhang HY; Wang JH
Med Mycol; 2013 Oct; 51(7):688-95. PubMed ID: 23527739
[TBL] [Abstract][Full Text] [Related]
23. Accuracy of galactomannan testing on tracheal aspirates in COVID-19-associated pulmonary aspergillosis.
Roman-Montes CM; Martinez-Gamboa A; Diaz-Lomelí P; Cervantes-Sanchez A; Rangel-Cordero A; Sifuentes-Osornio J; Ponce-de-Leon A; Gonzalez-Lara MF
Mycoses; 2021 Apr; 64(4):364-371. PubMed ID: 33217784
[TBL] [Abstract][Full Text] [Related]
24. Performance of the Euroimmun Aspergillus Antigen ELISA for the Diagnosis of Invasive Pulmonary Aspergillosis in Bronchoalveolar Lavage Fluid.
Egger M; Penziner S; Dichtl K; Gornicec M; Kriegl L; Krause R; Khong E; Mehta S; Vargas M; Gianella S; Porrachia M; Jenks JD; Venkataraman I; Hoenigl M
J Clin Microbiol; 2022 Apr; 60(4):e0021522. PubMed ID: 35350844
[TBL] [Abstract][Full Text] [Related]
25. [The diagnostic performance of galactomannan detection in invasive pulmonary aspergillosis with severe and critically ill influenza].
Lin PC; Zeng JH; Su SS; Zhou Y; Chen JJ; Chen CS; Li YP
Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(15):1050-1056. PubMed ID: 33878831
[No Abstract] [Full Text] [Related]
26. Evaluation of the diagnostic accuracy of galactomannan from the bronchoalveolar lavage fluid of patients with suspected invasive pulmonary aspergillosis.
Bernardi RM; Holler SR; Almeida EGC; Anton C; Machado FD; Silva DR
Rev Iberoam Micol; 2022; 39(2):31-35. PubMed ID: 35461766
[TBL] [Abstract][Full Text] [Related]
27. Risk Factors for Coronavirus Disease 2019 (COVID-19)-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Nationwide, Multicenter, Retrospective Cohort Study.
Kim SH; Hong JY; Bae S; Lee H; Wi YM; Ko JH; Kim B; Joo EJ; Seok H; Shi HJ; Yoo JR; Hyun M; Kim HA; Jang S; Mun SJ; Kim J; Kim MC; Jung DS; Kim SH; Peck KR
J Korean Med Sci; 2022 May; 37(18):e134. PubMed ID: 35535369
[TBL] [Abstract][Full Text] [Related]
28. [Diagnostic value of the combinations of bronchoalveolar lavage fluid galactomannan test and serum galactomannan test in invasive pulmonary aspergillosis].
Liu L; Li J; Dong H; Jiang L; Song H; Zhang S; Zhang Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Mar; 31(3):331-335. PubMed ID: 30914095
[TBL] [Abstract][Full Text] [Related]
29. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study.
Feys S; Gonçalves SM; Khan M; Choi S; Boeckx B; Chatelain D; Cunha C; Debaveye Y; Hermans G; Hertoghs M; Humblet-Baron S; Jacobs C; Lagrou K; Marcelis L; Maizel J; Meersseman P; Nyga R; Seldeslachts L; Starick MR; Thevissen K; Vandenbriele C; Vanderbeke L; Vande Velde G; Van Regenmortel N; Vanstapel A; Vanmassenhove S; Wilmer A; Van De Veerdonk FL; De Hertogh G; Mombaerts P; Lambrechts D; Carvalho A; Van Weyenbergh J; Wauters J
Lancet Respir Med; 2022 Dec; 10(12):1147-1159. PubMed ID: 36029799
[TBL] [Abstract][Full Text] [Related]
30. Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases.
Prattes J; Flick H; Prüller F; Koidl C; Raggam RB; Palfner M; Eigl S; Buzina W; Zollner-Schwetz I; Thornton CR; Krause R; Hoenigl M
Am J Respir Crit Care Med; 2014 Oct; 190(8):922-9. PubMed ID: 25203869
[TBL] [Abstract][Full Text] [Related]
31. [COVID-19-associated pulmonary aspergillosis in critically ill patients: experience of a Chilean public hospital].
Araya-Rojas F; Lasso-Barreto M
Rev Chilena Infectol; 2021 Dec; 38(6):754-760. PubMed ID: 35506848
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic Accuracy of Bronchoalveolar Lavage Fluid Galactomannan for Invasive Aspergillosis.
Cao XJ; Li YP; Xie LM; Zhang HL; Qin YS; Guo XG
Biomed Res Int; 2020; 2020():5434589. PubMed ID: 33335924
[TBL] [Abstract][Full Text] [Related]
33. [Galactomannan Tests of Bronchoalveolar Lavage Fluid for Diagnosing Invasive Pulmonary Aspergillosis].
Deng J; Wu SY; Liu Y; Ma Y; Xie Y; Chen ZX; Dai ZQ; Deng JL; Kang M
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):124-128. PubMed ID: 29737102
[TBL] [Abstract][Full Text] [Related]
34. Lower respiratory tract single-cell RNA sequencing and neutrophil extracellular trap profiling of COVID-19-associated pulmonary aspergillosis: a single centre, retrospective, observational study.
Feys S; Vanmassenhove S; Kraisin S; Yu K; Jacobs C; Boeckx B; Cambier S; Cunha C; Debaveye Y; Gonçalves SM; Hermans G; Humblet-Baron S; Jansen S; Lagrou K; Meersseman P; Neyts J; Peetermans M; Rocha-Pereira J; Schepers R; Spalart V; Starick MR; Thevissen K; Van Brussel T; Van Buyten T; Van Mol P; Vandenbriele C; Vanderbeke L; Wauters E; Wilmer A; Van Weyenbergh J; Van De Veerdonk FL; Carvalho A; Proost P; Martinod K; Lambrechts D; Wauters J
Lancet Microbe; 2024 Mar; 5(3):e247-e260. PubMed ID: 38280387
[TBL] [Abstract][Full Text] [Related]
35. Performance of the Bronchoalveolar Lavage Fluid Aspergillus Galactomannan Lateral Flow Assay With Cube Reader for Diagnosis of Invasive Pulmonary Aspergillosis: A Multicenter Cohort Study.
Jenks JD; Prattes J; Frank J; Spiess B; Mehta SR; Boch T; Buchheidt D; Hoenigl M
Clin Infect Dis; 2021 Oct; 73(7):e1737-e1744. PubMed ID: 32866234
[TBL] [Abstract][Full Text] [Related]
36. Usefulness of Two Aspergillus PCR Assays and Aspergillus Galactomannan and β-d-Glucan Testing of Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis.
Urabe N; Sakamoto S; Sano G; Suzuki J; Hebisawa A; Nakamura Y; Koyama K; Ishii Y; Tateda K; Homma S
J Clin Microbiol; 2017 Jun; 55(6):1738-1746. PubMed ID: 28330887
[TBL] [Abstract][Full Text] [Related]
37. The diagnosis of invasive and noninvasive pulmonary aspergillosis by serum and bronchoalveolar lavage fluid galactomannan assay.
Zhang S; Wang S; Wan Z; Li R; Yu J
Biomed Res Int; 2015; 2015():943691. PubMed ID: 25685819
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic Value of Galactomannan in Bronchoalveolar Lavage Fluid for Chronic Respiratory Disease with Pulmonary Aspergillosis.
Lai G; Zeng C; Mo J; Song WD; Xu P
J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31941687
[TBL] [Abstract][Full Text] [Related]
39. Does galactomannan testing increase diagnostic accuracy for IPA in the ICU? A prospective observational study.
Schroeder M; Simon M; Katchanov J; Wijaya C; Rohde H; Christner M; Laqmani A; Wichmann D; Fuhrmann V; Kluge S
Crit Care; 2016 May; 20(1):139. PubMed ID: 27160692
[TBL] [Abstract][Full Text] [Related]
40. Comparing the diagnostic value of bronchoalveolar lavage fluid galactomannan, serum galactomannanan, and serum 1,3-β-d-glucan in non-neutropenic respiratory disease patients with invasive pulmonary aspergillosis.
Dai Z; Cai M; Yao Y; Zhu J; Lin L; Fang L; Li Z; Yi H; Chen B; Liang X
Medicine (Baltimore); 2021 Apr; 100(14):e25233. PubMed ID: 33832082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
